Do you want to read an article? Please log in or register.
Breaking the therapeutic ceiling in drug development in ulcerative colitis
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development
Clin Gastroenterol Hepatol.
Reinisch W, Gottlieb K, Colombel JF, Danese S, Panaccione R, Panes J, Peyrin-Biroulet L, Rubin D, Sands BE, Schreiber S, Vermeire S, Mulberg A, Sandborn B
doi: 10.1016/j.cgh.2018.10.032.
Inflammatory Bowel Disease
Non-biological therapeutic management of ulcerative colitis
Expert Opin Pharmacother.
Mezzina N, Campbell Davies SE, Ardizzone S
doi: 10.1080/14656566.
RECOMMENDED
Inflammatory Bowel Disease
DUBLIN (Degree of Ulcerative colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in Ulcerative Colitis
J Crohns Colitis.
Rowan CR, Cullen G, Mulcahy HE, Sheridan J, Moss AC, Ryan EJ,
Doherty GA
doi: 10.1093/ecco-jcc/jjz067.
Inflammatory Bowel Disease
Segmental colectomy for ulcerative colitis: is there a place in selected patients without active colitis ? An international multicentric retrospective study in 72 patients
J Crohns Colitis.
Frontali A, Cohen L, Bridoux V, Myrelid P, Sica G, Poggioli G, Espin E, Beyer-Berjot L, Laharie D, Spinelli A, Zerbib P, Sampietro G, Frasson M, Louis E, Danese S, Fumery M, Denost Q, Altwegg R, Nancey S, Michelassi F, Treton X, Panis Y
doi: 10.1093/ecco-jcc/jjaa107.
RECOMMENDED
Inflammatory Bowel Disease
Positioning therapies in ulcerative colitis
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Gastroenterol Hepatol.
Danese S, Fiorino G, Peyrin-Biroulet L
doi: 10.1016/j.cgh.2020.01.017.
Inflammatory Bowel Disease
Immunogenicity of Golimumab and its Clinical Relevance in Patients With Ulcerative Colitis
Inflamm Bowel Dis.
Adedokun OJ, Gunn GR 3rd, Leu JH, Gargano C, Xu Z, Sandborn WJ, Rutgeerts P5, Shankar G
doi: 10.1093/ibd/izz003.
Inflammatory Bowel Disease
Small molecule oral targeted therapies in ulcerative colitis
Lancet Gastroenterol Hepatol.
Shivaji UN, Nardone OM, Cannatelli R, Smith SC, Ghosh S, Iacucci M
doi: 10.1016/S2468-1253(19)30414-5.
Inflammatory Bowel Disease
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme
J Crohns Colitis
Winthrop KL, Loftus EV Jr, Baumgart DC, Reinisch W, Nduaka CI, Lawendy N, Chan G, Mundayat R, Friedman GS, Salese L, Thorpe AJ, Su C
doi: 10.1093/ecco-jcc/jjaa233
Inflammatory Bowel Disease
Vedolizumab Trough Levels and Histological Healing During Maintenance Therapy in Ulcerative Colitis
J Crohns Colitis.
Pouillon L, Rousseau H, Busby-Venner H, De Carvalho Bittencourt M, Choukour M, Gauchotte G, Zallot C, Danese S, Baumann C, Peyrin-Biroulet L
doi: 10.1093/ecco-jcc/jjz029.